- 1. HL7 Clinical Document Architecture Level One document
- (UMLS (HL7) C1548463) =Intellectual Product ;
=Subtype of referenced data;
| - 21. HLA C antigen
- [Class I human histocompatibility (HLA) antigens encoded by a small cluster of structural genes at the C locus on chromosome 6. They have significantly lower immunogenicity than the HLA-A and -B determinants and are therefore of minor importance in donor/recipient crossmatching. Their primary role is their high-risk association with certain disease manifestations (e.g., spondylarthritis, psoriasis, multiple myeloma). ( MSH )] (UMLS (CSP) C0019751) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 2. HL7 Code System Type
- (UMLS (HL7) C1553870) =Intellectual Product =CodeSystem;
=External;
Internal;
Internal;
| - 22. HLA Class I Histocompatibility Antigen, A-2 Alpha Chain
- [Encoded by human HLA-A (A2 allele) Gene (HLA Family), HLA-A2 Antigen is a 365-aa 41-kD class I alpha heavy chain glycoprotein heterodimerized with 11.6-kD beta-2 microglobulin. HLA-A protein organization includes a signal peptide, extracellular alpha1, 2, and 3 domains (90-aa each), a transmembrane region, and a cytoplasmic tail. Polymorphic alpha1 and 2 domains determine peptide binding specificity. Ig-like alpha3 mediates CD8 binding on cytotoxic T-lymphocytes. In the immune response, HLA antigens mediate antigen presentation to TCR. HLA-A2 subtypes are associated with decreased risk of HIV-1 infection and increased frequency of early-onset Alzheimer disease. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0019733) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 3. HL7 Coded Concept Status
- (UMLS (HL7) C1553873) =Intellectual Product =CodeSystem;
=Proposed;
Active;
Retired;
Deleted | - 23. HLA Class II Histocompatibility Antigen DRB
- [HLA class II DR beta chain proteins (26-28 kD) form heterodimers with alpha (DRA) chains, both anchored in the membrane. Expressed in antigen presenting cells (B lymphocytes, dendritic cells, macrophages), alpha/beta heterodimers present peptides derived from extracellular proteins. Hundreds of DRB alleles have been described and typing for these polymorphisms is done for transplantation. (NCI) ( NCI )] (UMLS (NCI) C1333901) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 4. HL7 Defined Codes where nnnn is the HL7 table number
- (UMLS (HL7) C1550209) =Intellectual Product =Code;
| - 24. HLA Class II Histocompatibility Antigen, DP(W4) Beta Chain
- [Major Histocompatibility Complex, Class II, DP Beta 1 is encoded by the HLA-DPB1 gene. HLA-DPB, an HLA class II beta chain paralogue, plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). HLA-DPB is a heterodimer consisting of an alpha (DPA) and a beta chain (DPB), both anchored in the membrane. The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the HLA-DPB molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to 4 different molecules. (from LocusLink) ( NCI )] (UMLS (NCI) C0122007) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 5. HL7 ITS Version Code
- [HL7 implementation technology specification versions. These codes will document the ITS type and version for message encoding. The code will appear in the instances based upon rules expressed in the ITS, and do not appear in the abstract message, either as it is presented to received from the ITS. ( HL7V3.0 )] (UMLS (HL7) C1555717) =Intellectual Product =CodeSystem;
=XMLV1PR1;
| - 25. HLA D antigen
- [Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. ( MSH )] (UMLS (CSP) C0019754) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 6. HL7 set of units of measure
- (UMLS (HL7) C1550183) =Intellectual Product =Code;
| - 26. HLA DP antigen
- [A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. ( MSH )] (UMLS (CSP) C0019759) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 7. HL7 Specified or Mandated
- [HL7 Specified or Mandated ( HL7V3.0 )] (UMLS (HL7) C1552074) =Idea or Concept =CodingRationale;
| - 27. HLA DQ antigen
- [Polymorphic glycoproteins which are expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes. Certain HLA-DQ protein variants are associated with susceptibility to insulin-dependent diabetes mellitus and several autoimmune diseases. ( NCI )] (UMLS (CSP) C0019761) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 8. HL7 Text
- [For compatibility, this represents the HL7 v2.x FT data type. Its use is recommended only for backward compatibility with HL7 v2.x systems. ( HL7V3.0 )] (UMLS (HL7) C1554985) =Idea or Concept =TextMediaType;
| - 28. HLA DR antigen
- [Encoded by multiple HLA-DRA and HLA-DRB genes in a complex variable 5 cM region of MHC between HLA-B and -D, HLA-DR Antigens are Class II histocompatibility transmembrane glycoprotein heterodimers of alpha (heavy, 35-kD) and beta (light, 27-kD) chains. Located predominantly on B cells and macrophages, HLA-DR antigens function in antigen presentation to regulatory T cells in the immune response and in self/nonself discrimination. Invariant alpha and polymorphic beta chains have glycosylated N-termini, hydrophobic membrane regions, and hydrophilic C-termini. The heterodimer consists of 4 extracellular domains; invariant alpha-1, polymorphic N-terminal beta-1, and conserved Ig-like alpha-2 and beta-2. Alpha-1 and alpha-2 contain disulfide loops. Beta-1 contains 2 small variable regions. Alpha sequences have relatively simple structure; beta chains carry the major polymorphic determinants. ( NCI )] (UMLS (CSP) C0019764) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 9. HL7 Value Set and Coded Concept Property Codes
- (UMLS (HL7) C1553878) =Intellectual Product =CodeSystem;
=applies to;
how applies;
open issue;
ISO Object Identifier;
inverted relationship name;
| - 29. HLA G antigen
- [ ] (UMLS (CSP) C0082920) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 10. HL7 Version V3-2003-12
- [The consistent set of messaging artefacts as published or contained in repositories in December of 2003, based on the latest version of any V3 models or artefacts (RIM, Datatypes, CMETS, Common Messages, Vocabularies) as available in December of 2003. Note: This versioncode does not cover the version of the XML ITS. ( HL7V3.0 )] (UMLS (HL7) C1552550) =Intellectual Product ;
=HL7StandardVersionCode;
| - 30. HLA gene
- [ ] (UMLS (CSP) C0599797) =Gene or Genome ;
|
- 11. HL7CommitteeIDInRIM
- [Holds the codes used to identify the committees and SIGS of HL7 in RIM repository tables. ( HL7V3.0 )] (UMLS (HL7) C1553824) =Intellectual Product =CodeSystem;
=Vocabulary Committee;
Modeling and Methodology;
Technical Steering Committee;
Control/Query/MasterFiles;
Patient Administration;
Orders/Observation;
Financial Management;
Medical records;
Scheduling;
Patient Care;
Structured Document Committee;
| - 31. HLA linkage
- [ ] (UMLS (CSP) C0599824) =Natural Phenomenon or Process ;
|
- 12. HL7ConformanceInclusion
- [These concepts represent theconformance requirments defined for including or valuing an element of an HL7 message. The concepts apply equally to conformance profiles defined for Version 2.x messgaes as defined by the Conformance SIG, and to the conformance columns for Version 3 messages as specified in the HMD. ( HL7V3.0 )] (UMLS (HL7) C1553825) =Intellectual Product =CodeSystem;
=Mandatory;
InclusionNotMandatory | - 32. HLA Matched
- (UMLS (HL7) C1548978) =Idea or Concept =Blood Product Processing Requirements;
|
- 13. HL7DefinedActCodes
- [Domain provides the root for HL7-defined detailed or rich codes for the Act classes. ( HL7V3.0 )] (UMLS (HL7) C1697993) =Intellectual Product =ActCode;
=Diet;
ActAdjudicationResultActionCode;
ActBillableTreatmentPlanCode;
ActClaimAttachmentCode;
ActControlVariable;
ActDetectedIssueManagementCode;
ActEncounterCode;
ActFinancialTransactionCode;
ActListCode;
ActMonitoringProtocolCode;
ActSpecObsCode;
ActContainerRegistrationCode;
ActCoverageConfirmationCode;
ActEncounterAccommodationCode;
ActIncidentCode;
ActInsurancePolicyCode;
ActInvoiceElementSummaryCode;
ActOrderCode;
ActProcedureCode;
ActAdjudicationGroupCode;
ActBillingArrangementCode;
ActSubstanceAdministrationCode;
ActCoverageLimitCode;
ActPaymentCode;
ActProductAcquisitionCode;
ActSpecimenTreatmentCode;
ActAccountCode;
ActAdjudicationCode;
ActAdjudicationInformationCode;
ActBoundedROICode;
ActDetectedIssueCode;
ActInvoiceElementCode;
ActInvoiceOverrideCode;
ActPharmacySupplyType;
ActRegistryCode;
HL7TriggerEventCode;
ROIOverlayShape;
SubstanceAdministrationActCode | - 33. HLA typing
- [ ] (UMLS (CSP) C0242318) =Laboratory Procedure ;
|
- 14. HL7DefinedRoseProperty
- [The property Ids that HL7 has defined for customizing Rational Rose. ( HL7V3.0 )] (UMLS (HL7) C1553826) =Intellectual Product =CodeSystem;
=History identifier;
Application Role;
Attribute Cardinality;
MIM Delete;
Mandatory;
Attribute may repeat;
Vocabulary domain;
Vocabulary strength;
Version 2 data type;
Version 2 Field reference;
Subject class;
State attribute;
Data type symbol;
Data type instantiated;
Primitive data type;
Reference data type;
HMD identifier;
Message type identifier;
Receiver responsibility;
Developing committee;
Model date;
Model description;
Model identifier;
Model name;
Model version;
Developing organization;
MIM Identifier;
Responsible committee ID;
End state;
Start state;
State transition;
Identifier | - 34. HLA-A
- [This gene is involved in immune responses and histocompatibility processes. ( NCI )] (UMLS (NCI) C1333899) HLA-A Gene;
Major Histocompatibility Complex, Class I, A Gene =Gene or Genome ;
|
- 15. HL7StandardVersionCode
- [This code system holds version codes for the Version 3 standards. Values are to be determined by HL7 and added with each new version of the HL7 Standard. ( HL7V3.0 )] (UMLS (HL7) C1553900) =Intellectual Product =CodeSystem;
=HL7 Version V3-2003-12;
Version3 Pre-release #1 | - 35. HLA-B
- [This gene plays a role in both immune responses and histocompatibility processes. ( NCI )] (UMLS (NCI) C1415561) HLA-B Gene;
Major Histocompatibility Complex, Class I, B Gene =Gene or Genome |
- 16. HL7TriggerEventCode
- [The trigger event referenced by the Control Act instance. Values are drawn from the available trigger events used in the release of HL7 identified by the versionCode. ( HL7V3.0 )] (UMLS (HL7) C1699640) =Intellectual Product ;
=HL7DefinedActCodes;
| - 36. HLA-C
- [This gene plays a role in immune responses. ( NCI )] (UMLS (NCI) C1415562) HLA-C Gene;
Major Histocompatibility Complex, Class I, C Gene =Gene or Genome |
- 17. HL7UpdateMode
- [The possible modes of updating that occur when an attribute is received by a system that already contains values for that attribute. ( HL7V3.0 )] (UMLS (HL7) C1553827) =Intellectual Product =CodeSystem;
=Delete;
Replace;
Ignore;
Key;
Verify;
SetUpdateMode | - 37. HLA-DPB1
- [This gene plays a critical regulatory role in antigen presentation and peptide binding specificity. ( NCI )] (UMLS (NCI) C1333900) HLA-DPB1 Gene;
Major Histocompatibility Complex, Class II, DP Beta 1 Gene =Gene or Genome ;
|
- 18. HLA A antigen
- [Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. ( MSH )] (UMLS (CSP) C0019728) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 38. HLA-DRB1
- [This gene is involved in immunoregulation and antigen presentation. The gene has several hundred alleles and polymorphism typing is routinely performed for bone marrow and kidney transplantation. ( NCI )] (UMLS (NCI) C1415576) HLA-DRB1 Gene;
Major Histocompatibility Complex, Class II, DR Beta 1 Gene =Gene or Genome |
- 19. HLA antigen
- [Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. ( MSH )] (UMLS (CSP) C0019721) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 39. HLAR agar test
- [Susceptibility, High Level Aminoglycoside Resistance agar test ( HL7V3.0 )] (UMLS (HL7) C1551401) =Laboratory Procedure =ObservationMethod;
|
- 20. HLA B antigen
- [Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. ( MSH )] (UMLS (CSP) C0019737) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 40. hLF(1-11)
- [A synthetic peptide corresponding to the first 11 N-terminal amino acids of human lactoferrin (hLF1-11) with potential antimicrobial activity. Human lactoferrin, a 692 amino acids glycoprotein belonging to the transferrin family of metal-binding proteins, can be found in milk and other secretory fluids as well as in polymononuclear cells and leukocytes. Human lactoferrin plays a role in the innate defense of mucosal surfaces and neutrophils. Although the exact mechanism through which this peptide exerts its effect has yet to be fully elucidated, hLF1-11 may seize iron, thereby limiting the availability of free iron for microorganisms in the body. hLF1-11 appears to be effective against a variety of bacteria and fungi, including the multidrug-resistant Acinetobacter baumannii, multidrug-resistant Staphylococcus aureus and fluconazole-resistant Candida albicans strains. ( NCI )] (UMLS (NCI) C1144139) Human Lactoferrin Peptide hLF1-11;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance |
home
